Cue Biopharma, Inc. (CUE)
28.74
+0.74
(+2.64%)
USD |
NASDAQ |
Sep 11, 16:00
28.83
+0.09
(+0.31%)
After-Hours: 20:00
Cue Biopharma Market Cap : 150.29M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 150.29M |
| September 10, 2026 | 146.42M |
| September 09, 2026 | 159.50M |
| September 08, 2026 | 156.88M |
| September 04, 2026 | 143.49M |
| September 03, 2026 | 144.70M |
| September 02, 2026 | 140.98M |
| September 01, 2026 | 148.72M |
| August 31, 2026 | 133.45M |
| August 28, 2026 | 145.80M |
| August 27, 2026 | 147.26M |
| August 26, 2026 | 150.87M |
| August 25, 2026 | 139.94M |
| August 24, 2026 | 121.22M |
| August 21, 2026 | 125.40M |
| August 20, 2026 | 128.70M |
| August 19, 2026 | 137.43M |
| August 18, 2026 | 134.40M |
| August 17, 2026 | 144.54M |
| August 14, 2026 | 178.85M |
| August 13, 2026 | 162.53M |
| August 12, 2026 | 159.08M |
| August 11, 2026 | 147.68M |
| August 10, 2026 | 84.97M |
| August 07, 2026 | 88.29M |
| Date | Value |
|---|---|
| August 06, 2026 | 87.93M |
| August 05, 2026 | 86.76M |
| August 04, 2026 | 86.59M |
| August 03, 2026 | 87.47M |
| July 31, 2026 | 87.37M |
| July 30, 2026 | 98.96M |
| July 29, 2026 | 91.18M |
| July 28, 2026 | 98.48M |
| July 27, 2026 | 106.03M |
| July 24, 2026 | 104.56M |
| July 23, 2026 | 107.72M |
| July 22, 2026 | 111.33M |
| July 21, 2026 | 108.93M |
| July 20, 2026 | 100.75M |
| July 17, 2026 | 101.44M |
| July 16, 2026 | 90.47M |
| July 15, 2026 | 92.75M |
| July 14, 2026 | 101.83M |
| July 13, 2026 | 100.66M |
| July 10, 2026 | 119.73M |
| July 09, 2026 | 118.85M |
| July 08, 2026 | 115.08M |
| July 07, 2026 | 108.70M |
| July 06, 2026 | 105.78M |
| July 02, 2026 | 92.00M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nurix Therapeutics, Inc. | 2.603B |
| Monte Rosa Therapeutics, Inc. | 1.199B |
| Xilio Therapeutics, Inc. | 58.76M |
| ACADIA Pharmaceuticals, Inc. | 4.790B |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
Market Cap Related Metrics
| PS Ratio | 3.472 |
| PEG Ratio | -0.0036 |
| Price to Book Value | 65.06 |
| Price | 28.74 |
| Earnings Yield | -93.95% |
| PEGY Ratio | -0.0036 |